Russell Investments Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Russell Investments Group’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,930	Closed	-$24K	–	3215
2020 Q1	$24K	Buy	+2,930	New	+$41K	﹤0.01%	2936
2018 Q4	–	Sell	-10,166	Closed	-$219K	–	3053
2018 Q3	$219K	Buy	+10,166	New	+$309K	﹤0.01%	2625
2017 Q2	–	Sell	-4,508	Closed	-$978K	–	3056
2017 Q1	$978K	Buy	+4,508	New	+$644K	﹤0.01%	2107

Other funds holding LUMO

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IFG

Investors Financial Group Plymouth, Minnesota $215M AUM 19.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Russell Investments Group's LUMO Position: Q2 2020 in Review

Russell Investments Group sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2020, closing a stake of 2,930 shares — an estimated $24K sold.

Russell Investments Group first reported a position in LUMO in Q1 2017 and held it in 3 quarters. The position peaked at $978K in Q1 2017. 43 funds tracked by Wall St. Rank hold LUMO as of Q2 2020.

Russell Investments Group reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Russell Investments Group sold 2,930 Lumos Pharma, Inc. Common Stock shares in Q2 2020, an estimated $24K.
Russell Investments Group first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2017 and held it in 3 quarters.
Russell Investments Group's Lumos Pharma, Inc. Common Stock position peaked at $978K in Q1 2017.
43 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2020.

Based on Russell Investments Group's 13F filing for Q2 2020, filed 5 Aug 2020.